|Bid price||425.00||Open price||425.00|
|Ask price||426.00||Prev close||426.00|
Register now for FREE live Abcam share prices, Abcam stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Abcam Level 2 Data, indepth research tools and investor commentary for Abcam (ABC) and other London Stock Exchange equities.
Register now for FREE Abcam share price charts
|Sector||Pharmaceuticals & Biotechnology||ISIN||GB00B6774699|
|Activites||Abcam plc is a producer and distributor of research-grade antibodies and associated products headquartered in Cambridge, UK, with a US office located in Cambridge, Massachusetts and a Japan office located in Tokyo.||Index||n/a|
|Latest Share Price (p)||426.00||Net Gearing (%)||-2.88|
|Market Capitalisation (£m)||997.24||Gross Gearing (%)||14.83|
|Shares in issue (m)||199.75||Debt Ratio||6.41|
|P/E Ratio||30.22||Debt-to-Equity Ratio||0.39|
|Total dividends per share (p)||7.04||Assets / Equity Ratio||1.17|
|Dividend Yield (%)||1.41||Price to book value||5.86|
|Dividend cover (x)||2.18||ROCE||0.26|
|Earning per share (p)||16.52||EPS Growth (%)||20.41|
|52 week high / low||533.50 / 387.50||DPS Growth (%)||16.36|
|Dec.Date||Type||Director||Pos||No. of Shares|
Jonathan Milner, Chief Executive Officer, exercised 357,136 shares in the company on the 7th March 2014 at a price of 0.20p. The Director now holds 27,155,855 shares. Story provided by StockMarketWire.com Director deals data provided by www.directorsholdings.com
Jonathan Milner, Chief Executive Officer, exercised 16,590 shares in the company on the 7th March 2014 at a price of 180.80p. The Director now holds 26,798,719 shares. Story provided by StockMarketWire.com Director deals data provided by www.directorsholdings.com
Jonathan Milner, Chief Executive Officer, exercised 230,020 shares in the company on the 7th March 2014 at a price of 82.60p. The Director now holds 26,782,129 shares. Story provided by StockMarketWire.com Director deals data provided by www.directorsholdings.com
Register now for FREE Abcam company news
Abcam markets research-grade antibodies to academic and commercial users and is headquartered in Cambridge, UK, with a US office in Cambridge, Massachusetts. Its online catalogue of more than 17,000 products is supported by continually updated technical data created by the Company. *...
Everytime I go from one page to another this stupid site logs me out. Stockwatch is particularly bad. Even when I am already logged in it asks me to log in again, and then takes me not to stockwatch but to the homepage. THIS IS INFURIATING!!! I will never pay for any service offered by this site...
Pickings a bit thin on the ground this week and I must admit that my trawl thru the S&P 500 was a bit half hearted. However, this one looks set for a trip back down after failing to make new highs, breaking suport at $52ish and forming, throughout 2002, what looks suspiciously like a shallow head...
Register now for FREE Abcam share price discussions